Advanced veterinary therapies
Our History
EquiCord was founded in 2012 by a multidisciplinary team of veterinarians, biologists, engineers and pharmacists.
After establishing ourselves as national leaders in advanced veterinary therapies, we decided to make the leap into the European pharmaceutical industry by conducting various safety/efficacy clinical trials and building pioneering GMP facilities in the veterinary biotechnology sector.
After years of research, in 2019 we received the first European license for a medicinal product based on Equine Umbilical Cord Mesenchymal Stem Cells (EUC-MSCs): HorStem®
Following the success of HorStem®, in 2022 EquiCord unanimously received marketing authorization for DogStem®: The world's first stem cell-based medicine for the treatment of canine osteoarthritis.
At EquiCord we seek to develop new medicines that improve the quality of life of patients without ever forgetting to apply the highest scientific rigor to our developments.
EquiCord has developed a manufacturing process that allows for the production of high-quality cells from equine umbilical cord tissue, enabling non-invasive cell collection while prioritizing animal welfare. Obtaining umbilical cord cells offers a competitive advantage over other stem cell sources, providing a younger starting material with greater proliferative capacity and enhanced safety compared to other sources such as adipose tissue, bone marrow, or peripheral blood.
EquiCord's laboratories have been specifically designed for the manufacture of HorStem® and DogStem®, aiming to optimize industrial processes and ensure the highest quality for our products. We also have an on-site quality control laboratory that allows us to perform quality control checks according to the highest European standards.
Industrial Engineer. Extensive experience in industrial companies.
Doctor in Veterinary Medicine (DVM), Masters in Research and Development of medicines, PhD in physiology & pharmacology.
Bachelor degree in Biology, Masters in Cell Therapies Targets MCs.
Bachelor degree in Pharmacists, Masters in pharma industry.
Bachelor degree in Biology & Masters in Pharmacological Research.
